David Halverson

1.4k total citations
9 papers, 89 citations indexed

About

David Halverson is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Halverson has authored 9 papers receiving a total of 89 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Halverson's work include Cancer Genomics and Diagnostics (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). David Halverson is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). David Halverson collaborates with scholars based in United States, Malaysia and Croatia. David Halverson's co-authors include Ronald E. Gress, Charles W. Carter, Daniel H. Fowler, Gretchen N. Schwartz, Michael J. Pishvaian, Zev A. Wainberg, Andrew Hendifar, Samuel J. Klempner, Emanuel F. Petricoin and R Joseph Bender and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Stem Cells.

In The Last Decade

David Halverson

8 papers receiving 88 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Halverson United States 4 44 42 29 19 16 9 89
Fanny Fouyssac France 3 54 1.2× 56 1.3× 13 0.4× 21 1.1× 9 0.6× 4 97
Marissa S. Pioso United States 5 76 1.7× 48 1.1× 32 1.1× 16 0.8× 44 2.8× 7 147
Alice Piapi United Kingdom 5 49 1.1× 28 0.7× 15 0.5× 18 0.9× 37 2.3× 8 96
Natasha Silke Australia 6 32 0.7× 35 0.8× 21 0.7× 19 1.0× 87 5.4× 9 127
Ria Uhlig Germany 3 44 1.0× 23 0.5× 10 0.3× 17 0.9× 24 1.5× 6 79
Siarhei Kandabarau Germany 4 32 0.7× 30 0.7× 24 0.8× 10 0.5× 22 1.4× 14 82
Seishi Ogawa Japan 5 31 0.7× 24 0.6× 14 0.5× 14 0.7× 58 3.6× 26 114
Véronique Vergé France 6 40 0.9× 81 1.9× 9 0.3× 21 1.1× 47 2.9× 20 125
Valeria Cazzaniga Italy 4 22 0.5× 33 0.8× 19 0.7× 29 1.5× 61 3.8× 7 129
Michael Rainone United States 4 66 1.5× 15 0.4× 29 1.0× 9 0.5× 19 1.2× 8 83

Countries citing papers authored by David Halverson

Since Specialization
Citations

This map shows the geographic impact of David Halverson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Halverson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Halverson more than expected).

Fields of papers citing papers by David Halverson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Halverson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Halverson. The network helps show where David Halverson may publish in the future.

Co-authorship network of co-authors of David Halverson

This figure shows the co-authorship network connecting the top 25 collaborators of David Halverson. A scholar is included among the top collaborators of David Halverson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Halverson. David Halverson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Blais, Edik M., Steven J. Cohen, David Halverson, et al.. (2023). Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therapy. JCO Precision Oncology. 7(7). e2200648–e2200648. 1 indexed citations
2.
Guan, Michelle, R Joseph Bender, Michael J. Pishvaian, et al.. (2018). Molecular and clinical characterization of BRAF mutations in pancreatic ductal adenocarcinomas (PDACs).. Journal of Clinical Oncology. 36(4_suppl). 214–214. 29 indexed citations
3.
Madhavan, Subha, Edik M. Blais, R Joseph Bender, et al.. (2018). A cloud-based virtual tumor board to facilitate treatment recommendations for patients with advanced cancers.. Journal of Clinical Oncology. 36(15_suppl). 6508–6508. 2 indexed citations
4.
Petricoin, Emanuel F., R Joseph Bender, David Halverson, et al.. (2018). Precision medicine for pancreatic cancer patients:preliminary results from the know your tumor program.. Journal of Clinical Oncology. 36(15_suppl). 4126–4126.
5.
Steinberg, Seth M., Sri Harsha Tella, Jennifer L. Hsu, et al.. (2016). Characterization and Risk Factor Analysis of Osteoporosis in a Large Cohort of Patients with Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 22(8). 1517–1524. 11 indexed citations
6.
Hakim, Frances T., Sarfraz Memon, Ping Jin, et al.. (2015). Upregulation of Interferon-Inducible and Damage Response Receptors in Chronic Graft-Versus-Host Disease. Blood. 126(23). 922–922. 1 indexed citations
7.
Castiello, Luciano, Miriam E. Mossoba, Marianna Sabatino, et al.. (2013). Differential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cells. Cytotherapy. 15(5). 598–609. 2 indexed citations
8.
Halverson, David, Gretchen N. Schwartz, Charles W. Carter, Ronald E. Gress, & Daniel H. Fowler. (1997). In Vitro Generation of Allospecific Human CD8+ T Cells of Tc1 and Tc2 Phenotype. Blood. 90(5). 2089–2096. 39 indexed citations
9.
Warren, M K, JoAnne Zujewski, Wendy L. Rose, et al.. (1996). Early Suppressive Effects of Chemotherapy on Recovery of Bone Marrow Megakaryocyte Precursors: Possible Relationship to Platelet Recovery. Stem Cells. 14(S1). 31–37. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026